250 related articles for article (PubMed ID: 24776743)
1. A novel, potent dual inhibitor of Arg-gingipains and Lys-gingipain as a promising agent for periodontal disease therapy.
Kataoka S; Baba A; Suda Y; Takii R; Hashimoto M; Kawakubo T; Asao T; Kadowaki T; Yamamoto K
FASEB J; 2014 Aug; 28(8):3564-78. PubMed ID: 24776743
[TBL] [Abstract][Full Text] [Related]
2. Suppression of virulence of Porphyromonas gingivalis by potent inhibitors specific for gingipains.
Kadowaki T; Yamamoto K
Curr Protein Pept Sci; 2003 Dec; 4(6):451-8. PubMed ID: 14683430
[TBL] [Abstract][Full Text] [Related]
3. The role of gingipains in the pathogenesis of periodontal disease.
Imamura T
J Periodontol; 2003 Jan; 74(1):111-8. PubMed ID: 12593605
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a novel and potent inhibitor of Arg-gingipain from Streptomyces sp. strain FA-70.
Kadowaki T; Kitano S; Baba A; Takii R; Hashimoto M; Katunuma N; Yamamoto K
Biol Chem; 2003 Jun; 384(6):911-20. PubMed ID: 12887058
[TBL] [Abstract][Full Text] [Related]
5. Suppression of gingival inflammation induced by Porphyromonas gingivalis in rats by leupeptin.
Kitano S; Irimura K; Sasaki T; Abe N; Baba A; Miyake Y; Katunuma N; Yamamoto K
Jpn J Pharmacol; 2001 Jan; 85(1):84-91. PubMed ID: 11243579
[TBL] [Abstract][Full Text] [Related]
6. [Gingipains as the determinants of periodontopathogenicity].
Kadowaki T; Takii R; Baba A; Yamamoto K
Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):37-44. PubMed ID: 12843571
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Porphyromonas gingivalis proteinases (gingipains) by chlorhexidine: synergistic effect of Zn(II).
Cronan CA; Potempa J; Travis J; Mayo JA
Oral Microbiol Immunol; 2006 Aug; 21(4):212-7. PubMed ID: 16842504
[TBL] [Abstract][Full Text] [Related]
8. The biphasic virulence activities of gingipains: activation and inactivation of host proteins.
Imamura T; Travis J; Potempa J
Curr Protein Pept Sci; 2003 Dec; 4(6):443-50. PubMed ID: 14683429
[TBL] [Abstract][Full Text] [Related]
9. Gingipains from Porphyromonas gingivalis W83 synergistically disrupt endothelial cell adhesion and can induce caspase-independent apoptosis.
Sheets SM; Potempa J; Travis J; Fletcher HM; Casiano CA
Infect Immun; 2006 Oct; 74(10):5667-78. PubMed ID: 16988242
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of the virulence of Porphyromonas gingivalis by using a specific synthetic Kgp protease inhibitor.
Curtis MA; Aduse Opoku J; Rangarajan M; Gallagher A; Sterne JA; Reid CR; Evans HE; Samuelsson B
Infect Immun; 2002 Dec; 70(12):6968-75. PubMed ID: 12438376
[TBL] [Abstract][Full Text] [Related]
11. Arg-gingipain is responsible for the degradation of cell adhesion molecules of human gingival fibroblasts and their death induced by Porphyromonas gingivalis.
Baba A; Abe N; Kadowaki T; Nakanishi H; Ohishi M; Asao T; Yamamoto K
Biol Chem; 2001 May; 382(5):817-24. PubMed ID: 11517936
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses of periodontitis patients to gingipains of Porphyromonas gingivalis.
Inagaki S; Ishihara K; Yasaki Y; Yamada S; Okuda K
J Periodontol; 2003 Oct; 74(10):1432-9. PubMed ID: 14653388
[TBL] [Abstract][Full Text] [Related]
13. Suppression of inflammatory responses of human gingival fibroblasts by gingipains from Porphyromonas gingivalis.
Palm E; Khalaf H; Bengtsson T
Mol Oral Microbiol; 2015 Feb; 30(1):74-85. PubMed ID: 25055828
[TBL] [Abstract][Full Text] [Related]
14. A role for gingipains in cellular responses and bacterial survival in Porphyromonas gingivalis-infected cells.
Kadowaki T; Takii R; Yamatake K; Kawakubo T; Tsukuba T; Yamamoto K
Front Biosci; 2007 Sep; 12():4800-9. PubMed ID: 17569610
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of green tea catechins on cysteine proteinases in Porphyromonas gingivalis.
Okamoto M; Sugimoto A; Leung KP; Nakayama K; Kamaguchi A; Maeda N
Oral Microbiol Immunol; 2004 Apr; 19(2):118-20. PubMed ID: 14871352
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues.
Imamura T; Matsushita K; Travis J; Potempa J
Antimicrob Agents Chemother; 2001 Oct; 45(10):2871-6. PubMed ID: 11557483
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of gingipains by their profragments as the mechanism protecting Porphyromonas gingivalis against premature activation of secreted proteases.
Veillard F; Sztukowska M; Mizgalska D; Ksiazek M; Houston J; Potempa B; Enghild JJ; Thogersen IB; Gomis-Rüth FX; Nguyen KA; Potempa J
Biochim Biophys Acta; 2013 Aug; 1830(8):4218-28. PubMed ID: 23583629
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of the human C5A receptor by proteinases derived from Porphyromonas gingivalis: cleavage of leukocyte C5a receptor.
Jagels MA; Ember JA; Travis J; Potempa J; Pike R; Hugli TE
Adv Exp Med Biol; 1996; 389():155-64. PubMed ID: 8861006
[TBL] [Abstract][Full Text] [Related]
19. Roles for Arg- and Lys-gingipains in the disruption of cytokine responses and loss of viability of human endothelial cells by Porphyromonas gingivalis infection.
Baba A; Kadowaki T; Asao T; Yamamoto K
Biol Chem; 2002; 383(7-8):1223-30. PubMed ID: 12437109
[TBL] [Abstract][Full Text] [Related]
20. Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness.
Sugawara S; Nemoto E; Tada H; Miyake K; Imamura T; Takada H
J Immunol; 2000 Jul; 165(1):411-8. PubMed ID: 10861079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
